Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze
- Status
- COMPLETED
- Phase
- PHASE1
Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil
- Status
- TERMINATED
- Phase
- NA
Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1